Article (Scientific journals)
Tgfbeta-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.
Barnette, Damien; Hulin, Alexia; Ahmed, Ishtiaq et al.
2013In Journal of Molecular and Cellular Cardiology, 65, p. 137-146
Peer Reviewed verified by ORBi
 

Files


Full Text
Lincoln-Hulin2013- JMCC.pdf
Publisher postprint (1.71 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Animals; Animals, Newborn; Basic Helix-Loop-Helix Transcription Factors/metabolism; Chickens; Disease Models, Animal; Heart Valves/embryology/metabolism/pathology; Humans; MAP Kinase Signaling System; Mice; Mitral Valve/embryology/metabolism/pathology; NIH 3T3 Cells; Proteoglycans/metabolism; Smad Proteins/metabolism; Sus scrofa; Transforming Growth Factor beta/metabolism; Heart valve; MAPK; Myxomatous; Proteoglycan; Scleraxis; Tgfbeta
Abstract :
[en] Mature heart valves are complex structures consisting of three highly organized extracellular matrix layers primarily composed of collagens, proteoglycans and elastin. Collectively, these diverse matrix components provide all the necessary biomechanical properties for valve function throughout life. In contrast to healthy valves, myxomatous valve disease is the most common cause of mitral valve prolapse in the human population and is characterized by an abnormal abundance of proteoglycans within the valve tri-laminar structure. Despite the clinical significance, the etiology of this phenotype is not known. Scleraxis (Scx) is a basic-helix-loop-helix transcription factor that we previously showed to be required for establishing heart valve structure during remodeling stages of valvulogenesis. In this study, we report that remodeling heart valves from Scx null mice express decreased levels of proteoglycans, particularly chondroitin sulfate proteoglycans (CSPGs), while overexpression in embryonic avian valve precursor cells and adult porcine valve interstitial cells increases CSPGs. Using these systems we further identify that Scx is positively regulated by canonical Tgfbeta2 signaling during this process and this is attenuated by MAPK activity. Finally, we show that Scx is increased in myxomatous valves from human patients and mouse models, and overexpression in human mitral valve interstitial cells modestly increases proteoglycan expression consistent with myxomatous mitral valve phenotypes. Together, these studies identify an important role for Scx in regulating proteoglycans in embryonic and mature valve cells and suggest that imbalanced regulation could influence myxomatous pathogenesis.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Barnette, Damien;  Center for Cardiovascular and Pulmonary Res - Columbus - USA
Hulin, Alexia ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire de Biologie des Tissus Conjonctifs > PhD
Ahmed, Ishtiaq;  Indiana University School of medecine - Indianapolis, USA
Colige, Alain ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire de Biologie des Tissus Conjonctifs
Azhar, Mohamad;  Indianapolis School of Medicine - Indianapolis - USA
LINCOLN, Joy;  The Ohio State University, Columbus - USA > Department of Pediatrics
Language :
English
Title :
Tgfbeta-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.
Publication date :
December 2013
Journal title :
Journal of Molecular and Cellular Cardiology
ISSN :
0022-2828
eISSN :
1095-8584
Publisher :
Academic Press, London, United Kingdom
Volume :
65
Pages :
137-146
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 19 November 2013

Statistics


Number of views
114 (6 by ULiège)
Number of downloads
157 (2 by ULiège)

Scopus citations®
 
34
Scopus citations®
without self-citations
25
OpenCitations
 
41

Bibliography


Similar publications



Contact ORBi